Collectively, our data show that the CDK4/6-USP51-ZEB1 axis might play a key role in breast cancer metastasis, which can serve as a basis for the future development of therapeutic interventions in the treatment of advanced cancers. This evidence concerns the gene CDK4 and breast carcinoma.